Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Lykins Charmaine — Karuna Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Lykins Charmaine

Lykins Charmaine

Chief Commercial Officer at Karuna Therapeutics, Inc. · on record since Nov 30, 2021

Insider trading activity of Lykins Charmaine

Transactions on record: 1; since Nov 30, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Nov 30, 2021

Figures computed from official regulatory filings — methodology.

Companies where Lykins Charmaine has traded

Karuna Therapeutics, Inc.1 tx · Nov 30, 2021

Track record of Lykins Charmaine

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Lykins Charmaine

Co-insiders of Lykins Charmaine

Alexandria Venture Investments, LLCKaruna Therapeutics, Inc.
ARCH Venture Fund IX, L.P.Karuna Therapeutics, Inc.
ARCH Venture Fund IX Overage, L.P.Karuna Therapeutics, Inc.
ARCH Venture Partners IX, LLCKaruna Therapeutics, Inc.
ARCH Venture Partners IX, L.P.Karuna Therapeutics, Inc.
ARCH Venture Partners IX Overage, L.P.Karuna Therapeutics, Inc.
Brannan Stephen K.Karuna Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Brown Jason ParkerKaruna Therapeutics, Inc.

BYBEE CLINTONKaruna Therapeutics, Inc.

CHOWRIRA BHARAT MKaruna Therapeutics, Inc.

COUGHLIN CHRISTOPHER JKaruna Therapeutics, Inc.

CRANDELL KEITHKaruna Therapeutics, Inc.

HARRIGAN EDMUNDKaruna Therapeutics, Inc.

HEALY JAMESKaruna Therapeutics, Inc.

Ignelzi Troy A.Karuna Therapeutics, Inc.

JONAS JEFFREY MKaruna Therapeutics, Inc.

Kane William P JrKaruna Therapeutics, Inc.

Meury WilliamKaruna Therapeutics, Inc.

Miller Andrew CraigKaruna Therapeutics, Inc.

NELSEN ROBERTKaruna Therapeutics, Inc.

OLSON LAURIE JKaruna Therapeutics, Inc.

Pande AtulKaruna Therapeutics, Inc.

PAUL STEVEN MKaruna Therapeutics, Inc.

Preston HeatherKaruna Therapeutics, Inc.

PureTech Health LLCKaruna Therapeutics, Inc.

Torres DeniceKaruna Therapeutics, Inc.

Wheadon David E.Karuna Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Karuna Therapeutics, Inc.	Nov 30, 2021	AwardD	75,000	0.00 USD	$0	SEC